Heritability and molecular-genetic basis of resting EEG activity: a genome-wide association study.
- Authors
- Malone, Stephen M; Burwell, Scott J; Vaidyanathan, Uma; Miller, Michael B; McGue, Matt; Iacono, William G
- Year
- 2014
- Journal
- Psychophysiology
- PMID
- 25387704
- DOI
- 10.1111/psyp.12344
- PMCID
- PMC4262140
Several EEG parameters are potential endophenotypes for different psychiatric disorders. The present study consists of a comprehensive behavioral- and molecular-genetic analysis of such parameters in a large community sample (N = 4,026) of adolescent twins and their parents, genotyped for 527,829 single nucleotide polymorphisms (SNPs). Biometric heritability estimates ranged from .49 to .85, with a median of .78. The additive effect of all SNPs (SNP heritability) varied across electrodes. Although individual SNPs were not significantly associated with EEG parameters, several genes were associated with delta power. We also obtained an association between the GABRA2 gene and beta power (p < .014), consistent with findings reported by others, although this did not survive Bonferroni correction. If EEG parameters conform to a largely polygenic model of inheritance, larger sample sizes will be required to detect individual variants reliably.
Q-Q plot for SNP associations with alpha power at occipital-parietal leads. The 45° line gives the expected value under the null distribution. The area shaded in gray corresponds to the 95% acceptance region. Median and mean genomic control values are given in the inset in the upper left. N refers to the number of SNPs, which is 8 fewer than the number of SNPs on the array because there was no variation for 8 SNPs in this sample. Q-Q plots in GWAS give the observed p-values against the expected p-values under the null distribution of no association, although the additive inverse of the common log of p-values (−log10[p]) is used in order to emphasize small p-values. Because the vast majority of SNPs are not expected to be associated with a given phenotype, observed p-values should conform closely to their expected values, falling on or very close to the 45° line. The gray region in each plot depicts the 95% confidence region (null acceptance region).
Manhattan plot of individual SNP associations with beta power at Cz. Manhattan plots also depict the distribution of −log10(p) but are ordered by SNP location on a chromosome, which provides information about the location of any SNPs associated with small p-values. The horizontal line at 7.3 indicates the genome-wide significance level (5E-08). The horizontal line at 5 indicates E-05, which is sometimes used to indicate “suggestive” significance.
Manhattan plot of individual SNP associations with theta power at Cz. Manhattan plots also depict the distribution of −log10(p) but are ordered by SNP location on a chromosome, which provides information about the location of any SNPs associated with small p-values. The horizontal line at 7.3 indicates the genome-wide significance level (5E-08). The horizontal line at 5 indicates E-05, which is sometimes used to indicate “suggestive” significance.
Manhattan plot of individual SNP associations with delta power at Cz. Manhattan plots also depict the distribution of −log10(p) but are ordered by SNP location on a chromosome, which provides information about the location of any SNPs associated with small p-values. The horizontal line at 7.3 indicates the genome-wide significance level (5E-08). The horizontal line at 5 indicates E-05, which is sometimes used to indicate “suggestive” significance.
Manhattan plot of individual SNP associations with total power at Cz. Manhattan plots also depict the distribution of −log10(p) but are ordered by SNP location on a chromosome, which provides information about the location of any SNPs associated with small p-values. The horizontal line at 7.3 indicates the genome-wide significance level (5E-08). The horizontal line at 5 indicates E-05, which is sometimes used to indicate “suggestive” significance.
Manhattan plot of individual SNP associations with alpha peak frequency at occipital-parietal leads. Manhattan plots also depict the distribution of −log10(p) but are ordered by SNP location on a chromosome, which provides information about the location of any SNPs associated with small p-values. The horizontal line at 7.3 indicates the genome-wide significance level (5E-08). The horizontal line at 5 indicates E-05, which is sometimes used to indicate “suggestive” significance.
Associations between individual SNPs within or near GABRA2 and beta power. SNPs were imputed with reference to 1000 Genomes haplotypes (see text for additional detail). p-values produced by RFGLS analyses of the dosages for these imputed SNPs are expressed as −log10(p). SNP positions are from GRCh37 build 37 (hg19). Raw p-values are plotted in the upper panel. rs279858, which tags a haplotype associated with problematic alcohol use (Enoch, 2008), is indicated in black. The lower panel gives results are from a follow-up analysis that adjusts for effects of this SNP as an additional covariate, to determine to what extent the elevated p-values in the upper panel likely represent a single signal.
Q-Q plot for SNP associations with alpha power at Cz. The 45° line gives the expected value under the null distribution. The area shaded in gray corresponds to the 95% acceptance region. Median and mean genomic control values are given in the inset in the upper left. N refers to the number of SNPs, which is 8 fewer than the number of SNPs on the array because there was no variation for 8 SNPs in this sample. Q-Q plots in GWAS give the observed p-values against the expected p-values under the null distribution of no association, although the additive inverse of the common log of p-values (−log10[p]) is used in order to emphasize small p-values. Because the vast majority of SNPs are not expected to be associated with a given phenotype, observed p-values should conform closely to their expected values, falling on or very close to the 45° line. The gray region in each plot depicts the 95% confidence region (null acceptance region).
Q-Q plot for SNP associations with beta power at Cz. The 45° line gives the expected value under the null distribution. The area shaded in gray corresponds to the 95% acceptance region. Median and mean genomic control values are given in the inset in the upper left. N refers to the number of SNPs, which is 8 fewer than the number of SNPs on the array because there was no variation for 8 SNPs in this sample. Q-Q plots in GWAS give the observed p-values against the expected p-values under the null distribution of no association, although the additive inverse of the common log of p-values (−log10[p]) is used in order to emphasize small p-values. Because the vast majority of SNPs are not expected to be associated with a given phenotype, observed p-values should conform closely to their expected values, falling on or very close to the 45° line. The gray region in each plot depicts the 95% confidence region (null acceptance region).
Q-Q plot for SNP associations with theta power at Cz. The 45° line gives the expected value under the null distribution. The area shaded in gray corresponds to the 95% acceptance region. Median and mean genomic control values are given in the inset in the upper left. N refers to the number of SNPs, which is 8 fewer than the number of SNPs on the array because there was no variation for 8 SNPs in this sample. Q-Q plots in GWAS give the observed p-values against the expected p-values under the null distribution of no association, although the additive inverse of the common log of p-values (−log10[p]) is used in order to emphasize small p-values. Because the vast majority of SNPs are not expected to be associated with a given phenotype, observed p-values should conform closely to their expected values, falling on or very close to the 45° line. The gray region in each plot depicts the 95% confidence region (null acceptance region).
Q-Q plot for SNP associations with delta power at Cz. The 45° line gives the expected value under the null distribution. The area shaded in gray corresponds to the 95% acceptance region. Median and mean genomic control values are given in the inset in the upper left. N refers to the number of SNPs, which is 8 fewer than the number of SNPs on the array because there was no variation for 8 SNPs in this sample. Q-Q plots in GWAS give the observed p-values against the expected p-values under the null distribution of no association, although the additive inverse of the common log of p-values (−log10[p]) is used in order to emphasize small p-values. Because the vast majority of SNPs are not expected to be associated with a given phenotype, observed p-values should conform closely to their expected values, falling on or very close to the 45° line. The gray region in each plot depicts the 95% confidence region (null acceptance region).
Q-Q plot for SNP associations with total power at Cz. The 45° line gives the expected value under the null distribution. The area shaded in gray corresponds to the 95% acceptance region. Median and mean genomic control values are given in the inset in the upper left. N refers to the number of SNPs, which is 8 fewer than the number of SNPs on the array because there was no variation for 8 SNPs in this sample. Q-Q plots in GWAS give the observed p-values against the expected p-values under the null distribution of no association, although the additive inverse of the common log of p-values (−log10[p]) is used in order to emphasize small p-values. Because the vast majority of SNPs are not expected to be associated with a given phenotype, observed p-values should conform closely to their expected values, falling on or very close to the 45° line. The gray region in each plot depicts the 95% confidence region (null acceptance region).
Q-Q plot for SNP associations with alpha peak frequency at occipital-parietal leads. The 45° line gives the expected value under the null distribution. The area shaded in gray corresponds to the 95% acceptance region. Median and mean genomic control values are given in the inset in the upper left. N refers to the number of SNPs, which is 8 fewer than the number of SNPs on the array because there was no variation for 8 SNPs in this sample. Q-Q plots in GWAS give the observed p-values against the expected p-values under the null distribution of no association, although the additive inverse of the common log of p-values (−log10[p]) is used in order to emphasize small p-values. Because the vast majority of SNPs are not expected to be associated with a given phenotype, observed p-values should conform closely to their expected values, falling on or very close to the 45° line. The gray region in each plot depicts the 95% confidence region (null acceptance region).
Manhattan plot of individual SNP associations with alpha power at occipital-parietal leads. Manhattan plots also depict the distribution of −log10(p) but are ordered by SNP location on a chromosome, which provides information about the location of any SNPs associated with small p-values. The horizontal line at 7.3 indicates the genome-wide significance level (5E-08). The horizontal line at 5 indicates E-05, which is sometimes used to indicate “suggestive” significance.
Manhattan plot of individual SNP associations with alpha power at Cz. Manhattan plots also depict the distribution of −log10(p) but are ordered by SNP location on a chromosome, which provides information about the location of any SNPs associated with small p-values. The horizontal line at 7.3 indicates the genome-wide significance level (5E-08). The horizontal line at 5 indicates E-05, which is sometimes used to indicate “suggestive” significance.
| Name | Type |
|---|---|
| 1000 Genomes Project | cohort |
| acetylcholine | drug |
| Active withdrawal local | cohort |
| additive genetic influences | cohort |
| ADHD | phenotype |
| adolescent participants | cohort |
| adolescents | cohort |
| adults | cohort |
| aging | phenotype |
| alcohol | phenotype |
| alcohol dependence | phenotype |
| Alcohol_dependence | phenotype |
| alcohol dependence with comorbid antisocial behavior local | phenotype |
| alcoholism | phenotype |
| alcohol use and abuse local | phenotype |
| alpha activity | phenotype |
| alpha band | phenotype |
| alpha EEG power local | phenotype |
| alpha oscillations | phenotype |
| alpha peak frequency | phenotype |
| alpha power | phenotype |
| Alpha rhythm peak frequency local | phenotype |
| Alzheimer's disease | phenotype |
| Alzheimer’s disease | phenotype |
| antisocial personality disorder | phenotype |
| anxiety | phenotype |
| anxious arousal local | phenotype |
| apoE | gene |
| APOE ε4 | gene |
| ascending reticular formation local | anatomy |
| asymmetry in EEG activity local | phenotype |
| autism | phenotype |
| autism spectrum disorders | phenotype |
| basal forebrain neurons local | anatomy |
| behavioral phenotypes | phenotype |
| behavior problems | phenotype |
| benzodiazepines | drug |
| beta activity | phenotype |
| beta power | phenotype |
| Biometric Heritability Estimates local | phenotype |
| bipolar disorder | phenotype |
| cannabinoids | drug |
| Caucasian participants | cohort |
| cerebral hemispheres | anatomy |
| CEU haplotypes local | cohort |
| CEU sample of Caucasians local | cohort |
| Children with autism local | cohort |
| cholinergic pathways local | drug |
| cholinergic projections local | drug |
| Clu | gene |
| CLU variant local | variant |
| COGA sample | cohort |
| cognition | phenotype |
| cognitive processes | phenotype |
| Cognitive state local | phenotype |
| combined age cohorts local | cohort |
| common variants | cohort |
| Community volunteers local | cohort |
| COMT | gene |
| COMT Val158Met | gene |
| conduct disorder | phenotype |
| corticosterone | drug |
| CRH-BP local | gene |
| CRHBP | gene |
| Cz | anatomy |
| Cz electrode | anatomy |
| decision-making | phenotype |
| DEFA4 local | gene |
| DEFA6 local | gene |
| delta power | phenotype |
| depression | phenotype |
| disinhibitory psychopathology local | phenotype |
| Disinhibitory psychopathology local | phenotype |
| dopamine | drug |
| drinking-related behaviors local | phenotype |
| drowsiness | phenotype |
| drug dependence | phenotype |
| early onset of alcohol dependence local | phenotype |
| EEG | phenotype |
| EEG abnormalities local | phenotype |
| EEG_endophenotype local | phenotype |
| EEG frequency ranges local | phenotype |
| EEG measures local | phenotype |
| EEG parameter local | phenotype |
| EEG parameters | phenotype |
| EEG slow waves local | phenotype |
| EEG-specific candidate SNPs local | variant |
| Emotion | phenotype |
| endophenotype | phenotype |
| endophenotype-general candidate SNPs | variant |
| ES sample | cohort |
| externalizing disorders | phenotype |
| eye (superior electrode) local | anatomy |
| families | cohort |
| Family data local | cohort |
| first-degree relatives | cohort |
| four-member families local | cohort |
| frontal cortex | anatomy |
| GABA | phenotype |
| GABAA receptor | drug |
| GABAB receptor gene local | gene |
| GABAB receptor gene polymorphism local | variant |
| Gabra1 | gene |
| GABRA2 | gene |
| gene | gene |
| Generation Cohort local | cohort |
| genes | gene |
| Genetic Relatedness local | phenotype |
| glutamate | drug |
| HapMap | cohort |
| Head injury | phenotype |
| healthy controls | cohort |
| heavy drinking | phenotype |
| Heavy marijuana use local | phenotype |
| heritability | phenotype |
| higher frequencies local | phenotype |
| High frequency EEG power local | phenotype |
| high frequency oscillations | phenotype |
| high-risk offspring | cohort |
| hippocampus | anatomy |
| Hippocampus volume local | phenotype |
| Hodgkinson 2010 SNPs local | variant |
| Htr3b | gene |
| hyperactivity | phenotype |
| illicit drug use | phenotype |
| Illumina markers local | variant |
| Individuals in treatment local | cohort |
| individual_variant local | variant |
| intelligence | phenotype |
| late adolescence cohort local | cohort |
| latent externalizing dimension | phenotype |
| lateral parietal cortex | anatomy |
| linked earlobes local | anatomy |
| long-term potentiation | phenotype |
| lower frequencies local | phenotype |
| Low frequency EEG power local | phenotype |
| Low-frequency power local | phenotype |
| low-frequency power (delta and theta) local | phenotype |
| low-risk individuals | cohort |
| low-voltage alpha local | phenotype |
| LVA local | phenotype |
| marijuana | phenotype |
| McGue et al., 2013 local | cohort |
| MCTFR | cohort |
| MDMA | drug |
| MDMA use local | phenotype |
| memory | phenotype |
| methamphetamine | drug |
| Methamphetamine use local | phenotype |
| methylphenidate | drug |
| motor inhibition | phenotype |
| MTFS | cohort |
| neurological disorders | phenotype |
| nicotine | drug |
| Non-treatment samples local | cohort |
| Non-treatment seeking individuals local | cohort |
| noradrenaline | drug |
| noradrenergic modulation local | drug |
| normal controls | cohort |
| Normally developing children local | cohort |
| normal vision | phenotype |
| occipital cortex | anatomy |
| occipital-parietal local | anatomy |
| Occipital-parietal local | anatomy |
| occipital-parietal locations local | anatomy |
| ocular dominance columns local | anatomy |
| older cohort | cohort |
| opioid | drug |
| outer canthus local | anatomy |
| parents and offspring local | cohort |
| Perceptual state local | phenotype |
| phenotype | phenotype |
| posterior region | anatomy |
| prefrontal cortex | anatomy |
| present study | cohort |
| primary visual cortex | anatomy |
| psychiatric disorders | phenotype |
| Psychiatric Genomics Consortium | cohort |
| psychopathology | phenotype |
| psychophysiological_measure local | phenotype |
| relapse | phenotype |
| rest local | phenotype |
| resting EEG parameters local | phenotype |
| reward | phenotype |
| reward sensitivity | phenotype |
| rs279858 | variant |
| rs511310 local | variant |
| sample_used_here local | cohort |
| schizophrenia | phenotype |
| selective attention | phenotype |
| sensorimotor beta activity local | phenotype |
| serotonin | drug |
| SGIP1 | gene |
| shared environmental influence | phenotype |
| short-term memory | phenotype |
| sleep | phenotype |
| Sleepiness local | phenotype |
| slower alpha peak frequency local | phenotype |
| Slow-wave power local | phenotype |
| SNP | cohort |
| SNP heritability | phenotype |
| spatial working memory | phenotype |
| Stein et al., 2012 local | cohort |
| stepparents local | cohort |
| study cohort | cohort |
| substance abuse | phenotype |
| thalamocortical projections | anatomy |
| theta activity | phenotype |
| theta/alpha ratio local | phenotype |
| theta band | phenotype |
| theta-band activity local | phenotype |
| Theta-band activity local | phenotype |
| theta/beta ratio local | phenotype |
| theta oscillations | phenotype |
| total power | phenotype |
| Twin cohort | cohort |
| unique environmental influence local | phenotype |
| Val158/Met polymorphism local | variant |
| vertex | anatomy |
| women | cohort |
| working memory | phenotype |
| younger cohort | cohort |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| ADHD polygenic risk predicts neural signatures of cognitive control: Evidence from midfrontal theta dynamics. | Aydin Ü et al. | — | 2026 | → |
| Individual alpha peak predicts clinical response in TMS therapy for depression: An independent replication. | Baradits M et al. | — | 2026 | → |
| Number of Alpha Peaks in the Electroencephalogram Is Associated With Clinical Phenotype and Copy Number Variants in Youths With Autism. | Arutiunian V et al. | — | 2026 | → |
| Depression and anxiety are increased in autism and ADHD: Evidence from a young adult community-based sample. | Capp S et al. | — | 2025 | → |
| qEEG Neuromarkers of Complex Childhood Trauma in Adolescents. | Marcu GM et al. | — | 2025 | → |
| Reduced occurrence of alpha waves during resting state predicts high ADHD traits in young adults | Rodriguez-Larios J et al. | — | 2025 | — |
| Face processing in young adults with autism and ADHD: An event related potentials study. | Aydin Ü et al. | — | 2023 | → |
| A nonparametric Bayesian model for estimating spectral densities of resting-state EEG twin data. | Hart B et al. | — | 2022 | → |
| Human resting-state EEG and radiofrequency GSM mobile phone exposure: the impact of the individual alpha frequency. | Wallace J et al. | — | 2022 | → |
| Quality of life, functional impairment and continuous performance task event-related potentials (ERPs) in young adults with ADHD and autism: A twin study. | Aydin Ü et al. | — | 2022 | → |
| The Interactive Effect of Genetic and Epigenetic Variations in <i>FKBP5</i> and <i>ApoE</i> Genes on Anxiety and Brain EEG Parameters. | Kuznetsova IL et al. | — | 2022 | → |
| Using multivariate endophenotypes to identify psychophysiological mechanisms associated with polygenic scores for substance use, schizophrenia, and education attainment. | Harper J et al. | — | 2022 | → |
| Large-scale collaboration in ENIGMA-EEG: A perspective on the meta-analytic approach to link neurological and psychiatric liability genes to electrophysiological brain activity. | Smit DJA et al. | — | 2021 | → |
| Genome-Wide Scan for Five Brain Oscillatory Phenotypes Identifies a New QTL Associated with Theta EEG Band. | Rebelo MÂ et al. | — | 2020 | → |
| Discovering heritable modes of MEG spectral power. | Leppäaho E et al. | — | 2019 | → |
| Human brain arousal in the resting state: a genome-wide association study. | Jawinski P et al. | — | 2019 | → |
| Electrophysiological activity is associated with vulnerability of Internet addiction in non-clinical population. | Wang GY et al. | — | 2018 | → |
| Genome-wide association analysis links multiple psychiatric liability genes to oscillatory brain activity. | Smit DJA et al. | — | 2018 | → |
| Heritability of Sleep EEG Topography in Adolescence: Results from a Longitudinal Twin Study. | Markovic A et al. | — | 2018 | → |
| Toward a reliable, automated method of individual alpha frequency (IAF) quantification. | Corcoran AW et al. | — | 2018 | → |
| A genome wide association study of fast beta EEG in families of European ancestry. | Meyers JL et al. | — | 2017 | → |
| An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestry. | Meyers JL et al. | — | 2017 | → |
| GABA<sub>A</sub> receptor subtype involvement in addictive behaviour. | Stephens DN et al. | — | 2017 | → |
| Psychophysiological endophenotypes to characterize mechanisms of known schizophrenia genetic loci. | Liu M et al. | — | 2017 | → |
| What can time-frequency and phase coherence measures tell us about the genetic basis of P3 amplitude? | Malone SM et al. | — | 2017 | → |
| Whole genome sequence association and ancestry-informed polygenic profile of EEG alpha in a Native American population. | Peng Q et al. | — | 2017 | → |
| Brain Networks and α-Oscillations: Structural and Functional Foundations of Cognitive Control. | Sadaghiani S et al. | — | 2016 | → |
| Electrophysiological Endophenotypes for Schizophrenia. | Owens EM et al. | — | 2016 | → |
| One-year developmental stability and covariance among oddball, novelty, go/no-go, and flanker event-related potentials in adolescence: A monozygotic twin study. | Burwell SJ et al. | — | 2016 | → |
| Cracking the brain's genetic code. | Thompson PM | — | 2015 | → |
| Longitudinal stability and predictive utility of the visual P3 response in adults with externalizing psychopathology. | Yoon HH et al. | — | 2015 | → |
| Risky Business: Pathways to Progress in Biologically Informed Studies of Psychopathology. | Agrawal A et al. | — | 2015 | → |
| The importance of endophenotypes in schizophrenia research. | Braff DL | — | 2015 | → |
| The Power of Theory, Research Design, and Transdisciplinary Integration in Moving Psychopathology Forward. | Vaidyanathan U et al. | — | 2015 | → |
| Decomposing P300 to identify its genetic basis. | Ford JM | — | 2014 | → |
| Genetic associations of nonsynonymous exonic variants with psychophysiological endophenotypes. | Vrieze SI et al. | — | 2014 | → |
| Genome-wide scans of genetic variants for psychophysiological endophenotypes: a methodological overview. | Iacono WG et al. | — | 2014 | → |
| Heritability and molecular genetic basis of antisaccade eye tracking error rate: a genome-wide association study. | Vaidyanathan U et al. | — | 2014 | → |
| In search of rare variants: preliminary results from whole genome sequencing of 1,325 individuals with psychophysiological endophenotypes. | Vrieze SI et al. | — | 2014 | → |